Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian target of rapamycin.

Source:http://linkedlifedata.com/resource/pubmed/id/19706758

Cancer Res. 2009 Sep 15 69 18 7311-9

Download in:

View as

General Info

PMID
19706758